James M. Gower

2009

In 2009, James M. Gower earned a total compensation of $2M as Chief Executive Officer, Chairman of the Board and Director at Rigel Pharmaceuticals, a 47% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$504,000
Option Awards$890,682
Salary$600,000
Other$3,564
Total$1,998,246

Gower received $890.7K in option awards, accounting for 45% of the total pay in 2009.

Gower also received $504K in non-equity incentive plan, $600K in salary and $3.6K in other compensation.

Rankings

In 2009, James M. Gower's compensation ranked 2,377th out of 9,885 executives tracked by ExecPay. In other words, Gower earned more than 76.0% of executives.

ClassificationRankingPercentile
All
2,377
out of 9,885
76th
Division
Manufacturing
832
out of 3,690
78th
Major group
Chemicals And Allied Products
162
out of 866
81st
Industry group
Drugs
96
out of 638
85th
Industry
Pharmaceutical Preparations
76
out of 446
83rd
Source: SEC filing on April 12, 2012.

Gower's colleagues

We found four more compensation records of executives who worked with James M. Gower at Rigel Pharmaceuticals in 2009.

2009

Donald Payan

Rigel Pharmaceuticals

Executive Vice President, President of Discovery and Research

2009

Raul Rodriguez

Rigel Pharmaceuticals

Chief Operating Officer

2009

Elliott Grossbard

Rigel Pharmaceuticals

Chief Medical Officer

2009

Ryan Maynard

Rigel Pharmaceuticals

Chief Financial Officer

You may also like